Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant

Journal of the American College of Surgeons

Volumn 223, Issue 2, 2016, Pages 321-331.e1

  Wiggers, Jimme K ^a   Groot Koerkamp, Bas ^b   Cieslak, Kasia P ^a   Doussot, Alexandre ^c   van Klaveren, David ^b   Allen, Peter J ^c   Besselink, Marc G ^a   Busch, Olivier R ^a   D'Angelica, Michael I ^c   DeMatteo, Ronald P ^c   Gouma, Dirk J ^a   Kingham, T Peter ^c   van Gulik, Thomas M ^a   Jarnagin, William R ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADULT; AGE; BILE DUCT CARCINOMA; BILIARY TRACT DRAINAGE; BILIARY TRACT SURGERY; BILIRUBIN BLOOD LEVEL; CHOLANGITIS; CONFERENCE PAPER; FEMALE; FUTURE LIVER REMNANT; HEPATOBILIARY PARAMETERS; HUMAN; JAUNDICE; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RISK; PORTAL VEIN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; SEPSIS; SURGICAL MORTALITY; AGED; BILE DUCT NEOPLASMS; COMMON HEPATIC DUCT; DECISION SUPPORT SYSTEM; DRAINAGE; KLATSKIN TUMOR; MORTALITY; PREOPERATIVE CARE; PREOPERATIVE PERIOD; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; DECISION SUPPORT TECHNIQUES; DRAINAGE; FEMALE; HEPATECTOMY; HEPATIC DUCT, COMMON; HUMANS; KLATSKIN TUMOR; LOGISTIC MODELS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84969677471     PISSN: 10727515     EISSN: 18791190     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2016.03.035     Document Type: Conference Paper

References (42)

1. 1 Siegel, R., Ma, J., Zou, Z., Jemal, A., Cancer statistics, 2014. CA Cancer J Clin 64 (2014), 9–29.
2. 2 Ito, F., Agni, R., Rettammel, R.J., et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg 248 (2008), 273–279.
3. 3 Nagino, M., Ebata, T., Yokoyama, Y., et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg 258 (2013), 129–140.
4. 4 Nuzzo, G., Giuliante, F., Ardito, F., et al. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg 147 (2012), 26–34.
5. 5 Farges, O., Regimbeau, J.M., Fuks, D., et al. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg 100 (2013), 274–283.
6. 6 de Jong, M.C., Marques, H., Clary, B.M., et al. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer 118 (2012), 4737–4747.
7. 7 Kaiser, G.M., Paul, A., Sgourakis, G., et al. Novel prognostic scoring system after surgery for Klatskin tumor. Am Surg 79 (2013), 90–95.
8. 8 Blamey, S.L., Fearon, K.C., Gilmour, W.H., et al. Prediction of risk in biliary surgery. Br J Surg 70 (1983), 535–538.
9. 9 Belghiti, J., Hiramatsu, K., Benoist, S., et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191 (2000), 38–46.
10. 10 Dixon, J.M., Armstrong, C.P., Duffy, S.W., Davies, G.C., Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut 24 (1983), 845–852.
11. 11 Iacono, C., Ruzzenente, A., Campagnaro, T., et al. Role of preoperative biliary drainage in jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg 257 (2013), 191–204.
12. 12 Sakata, J., Shirai, Y., Tsuchiya, Y., et al. Preoperative cholangitis independently increases in-hospital mortality after combined major hepatic and bile duct resection for hilar cholangiocarcinoma. Langenbecks Arch Surg 394 (2009), 1065–1072.
13. 13 Kennedy, T.J., Yopp, A., Qin, Y., et al. Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma. HPB (Oxford) 11 (2009), 445–451.
14. 14 Shoup, M., Gonen, M., D'Angelica, M., et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 7 (2003), 325–330.
15. 15 Farges, O., Vibert, E., Cosse, C., et al. “Surgeons' intuition” versus “prognostic models”. Ann Surg 260 (2014), 923–930.
16. 16 Weldon, S.-M., Korkiakangas, T., Bezemer, J., Kneebone, R., Communication in the operating theatre. Br J Surg 100 (2013), 1677–1688.
17. 17 Corvera, C.U., Blumgart, L.H., Darvishian, F., et al. Clinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. J Am Coll Surg 201 (2005), 862–869.
18. 18 Erdogan, D., Kloek, J.J., ten Kate, F.J.W., et al. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg 95 (2008), 727–734.
19. 19 Farges, O., Goutte, N., Bendersky, N., et al. Incidence and risks of liver resection: an all-inclusive French nationwide study. Ann Surg 256 (2012), 697–704 discussion 705.
20. 20 Rahbari, N.N., Garden, O.J., Padbury, R., et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149 (2011), 713–724.
21. 21 van den Esschert, J.W., de Graaf, W., van Lienden, K.P., et al. Volumetric and functional recovery of the remnant liver after major liver resection with prior portal vein embolization: recovery after PVE and liver resection. J Gastrointest Surg 13 (2009), 1464–1469.
22. 22 Simpson, A.L., Geller, D.A., Hemming, A.W., et al. Liver planning software accurately predicts postoperative liver volume and measures early regeneration. J Am Coll Surg 219 (2014), 199–207.
23. 23 Vauthey, J.N., Chaoui, A., Do, K.A., et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127 (2000), 512–519.
24. 24 Martel, G., Cieslak, K.P., Huang, R., et al. Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resections. HPB (Oxford) 17 (2015), 1051–1057.
25. 25 van der Gaag, N.A., Rauws, E.A.J., van Eijck, C.H.J., et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 362 (2010), 129–137.
26. 26 Wiggers, J.K., Coelen, R.J., Rauws, E.A., et al. Preoperative endoscopic versus percutaneous transhepatic biliary drainage in potentially resectable perihilar cholangiocarcinoma (DRAINAGE trial): design and rationale of a randomized controlled trial. BMC Gastroenterol, 15, 2015, 20.
27. 27 Ruys, A.T., van Beem, B.E., Engelbrecht, M.R.W., et al. Radiological staging in patients with hilar cholangiocarcinoma: a systematic review and meta-analysis. Br J Radiol 85:1017 (2012), 1255–1262.
28. 28 Altman, D.G., Matthews, J.N., Statistics notes. Interaction 1: heterogeneity of effects. BMJ, 313(7055), 1996, 486.
29. 29 van Klaveren, D., Vergouwe, Y., Farooq, V., et al. Estimates of absolute treatment benefit for individual patients required careful modeling of statistical interactions. J Clin Epidemiol 68 (2015), 1366–1374.
30. 30 Janssen, K.J.M., Donders, A.R.T., Harrell, F.E., et al. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol 63 (2010), 721–727.
31. 31 Sullivan, L.M., Massaro, J.M., D'Agostino, R.B., Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 23 (2004), 1631–1660.
32. 32 Regimbeau, J.M., Fuks, D., Le Treut, Y.-P., et al. Surgery for hilar cholangiocarcinoma: a multi-institutional update on practice and outcome by the AFC-HC study group. J Gastrointest Surg 15 (2011), 480–488.
33. 33 Mansfield, S.D., Barakat, O., Charnley, R.M., et al. Management of hilar cholangiocarcinoma in the North of England: pathology, treatment, and outcome. World J Gastroenterol 11 (2005), 7625–7630.
34. 34 Walker, K., Neuburger, J., Groene, O., et al. Public reporting of surgeon outcomes: low numbers of procedures lead to false complacency. Lancet 382:9905 (2013), 1674–1677.
35. 35 Abdalla, E.K., Barnett, C.C., Doherty, D., et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 137 (2002), 675–680 discussion 80–81.
36. 36 Hemming, A.W., Reed, A.I., Howard, R.J., et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237 (2003), 686–691 discussion 691–693.
37. 37 Nagino, M., Kamiya, J., Nishio, H., et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg 243 (2006), 364–372.
38. 38 Yokoyama, Y., Nagino, M., Nimura, Y., Mechanism of impaired hepatic regeneration in cholestatic liver. J Hepatobiliary Pancreat Surg 14 (2007), 159–166.
39. 39 Hemming, A.W., Reed, A.I., Fujita, S., et al. Surgical management of hilar cholangiocarcinoma. Ann Surg 241 (2005), 693–699 discussion 699–702.
40. 40 Seyama, Y., Kubota, K., Sano, K., et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg 238 (2003), 73–83.
41. 41 Kloek, J.J., van der Gaag, N.A., Aziz, Y., et al. Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma. J Gastrointest Surg 14 (2010), 119–125.
42. 42 Kawakami, H., Kuwatani, M., Onodera, M., et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma. J Gastroenterol 46 (2011), 242–248.